217 related articles for article (PubMed ID: 27346976)
1. Concurrent acquired inhibitors to factor VIII and IX, a laboratory artifact: a case report.
Doma SA; Hillarp A; Pajič T; Andoljšek D; Černelč P; Preldžnik Zupan I
Biochem Med (Zagreb); 2016; 26(2):279-84. PubMed ID: 27346976
[TBL] [Abstract][Full Text] [Related]
2. Acquired inhibitors.
Cohen AJ; Kessler CM
Baillieres Clin Haematol; 1996 Jun; 9(2):331-54. PubMed ID: 8800509
[TBL] [Abstract][Full Text] [Related]
3. Laboratory identification of factor inhibitors: the perspective of a large tertiary hemophilia center.
Kershaw G; Jayakodi D; Dunkley S
Semin Thromb Hemost; 2009 Nov; 35(8):760-8. PubMed ID: 20169512
[TBL] [Abstract][Full Text] [Related]
4. Modification of the Bethesda assay for factor VIII or IX inhibitors to improve efficiency.
Gadarowski JJ; Czapek EE; Ontiveros JD; Pedraza JL
Acta Haematol; 1988; 80(3):134-8. PubMed ID: 3143212
[TBL] [Abstract][Full Text] [Related]
5. Screening of F.VIII:C antibodies by an enzyme-linked immunosorbent assay.
Mondorf W; Ehrenforth S; Vigh Z; Last J; Tippmann G; Kreuz W; Scharrer I
Vox Sang; 1994; 66(1):8-13. PubMed ID: 8146988
[TBL] [Abstract][Full Text] [Related]
6. Frequency of specific coagulation inhibitors and antiphospholipid antibodies in Tunisian haemophiliacs.
Kraiem I; Hadhri S; El Omri H; Sassi R; Chaabani W; Ennabli S; Skouri H
Ann Biol Clin (Paris); 2012; 70(6):659-65. PubMed ID: 23207810
[TBL] [Abstract][Full Text] [Related]
7. Acquired factor VIII inhibitor.
Simpson WG; Neefe J; Zang J; Drosick R; Kearns R
J Ky Med Assoc; 1991 Nov; 89(11):555-7. PubMed ID: 1748831
[TBL] [Abstract][Full Text] [Related]
8. Immunologically generated circulating anticoagulants in humans.
Edwards RL; Wakem CJ
Surv Immunol Res; 1984; 3(1):64-9. PubMed ID: 6426006
[No Abstract] [Full Text] [Related]
9. Laboratory identification of factor inhibitors: an update.
Kershaw G; Favaloro EJ
Pathology; 2012 Jun; 44(4):293-302. PubMed ID: 22531341
[TBL] [Abstract][Full Text] [Related]
10. The optimal treatment for haemophiliacs who have developed factor VIII or -IX antibodies.
Engelfriet CP; Reesink HW; Mannucci PM; Gringeri A; Ingerslev J; Brettler DB; Mauser-Bunschoten EP; Negrier C; Berntorp E; Smith OP; Shapiro AD
Vox Sang; 2000; 78(4):256-61. PubMed ID: 10970234
[No Abstract] [Full Text] [Related]
11. Nijmegen-Bethesda assay to measure factor VIII inhibitors.
Duncan E; Collecutt M; Street A
Methods Mol Biol; 2013; 992():321-33. PubMed ID: 23546724
[TBL] [Abstract][Full Text] [Related]
12. [Immune coagulation disorders (excluding antiphospholipid syndrome].
Arai M
Rinsho Byori; 2001 Oct; 49(10):1000-4. PubMed ID: 11769464
[TBL] [Abstract][Full Text] [Related]
13. Combined factor VIII and IX inhibitors in a girl.
Reussi C; Altman R; Rouvier J; Maino R
Thromb Diath Haemorrh; 1966 Dec; 16(3):549-58. PubMed ID: 5996674
[No Abstract] [Full Text] [Related]
14. Atypical spontaneous factor VIII inhibitor: specific diagnostics and therapy of acute bleeding.
Steinbrueckner B; Steigerwald U; Keller F; Ordung R; Neuenroth L; Reuther J; Klinker H; Schwender S
Acta Haematol; 1998; 99(2):102-5. PubMed ID: 9554460
[TBL] [Abstract][Full Text] [Related]
15. Acquired haemophilia A: errors in the diagnosis.
Kazmi MA; Pickering W; Smith MP; Holland LJ; Savidge GF
Blood Coagul Fibrinolysis; 1998 Oct; 9(7):623-8. PubMed ID: 9863711
[TBL] [Abstract][Full Text] [Related]
16. Spontaneous inhibitors to coagulation factors.
Green D
Clin Lab Haematol; 2000 Oct; 22 Suppl 1():21-5; discussion 30-2. PubMed ID: 11251655
[TBL] [Abstract][Full Text] [Related]
17. Systematic review of the presentation of coagulation factor VIII inhibitors in rheumatic diseases: A potential cause of life-threatening hemorrhage.
O'Connor CR
Semin Arthritis Rheum; 2015 Jun; 44(6):695-709. PubMed ID: 25595725
[TBL] [Abstract][Full Text] [Related]
18. ELISA system for detection of immune responses to FVIII: a study of 246 samples and correlation with the Bethesda assay.
Sahud MA; Pratt KP; Zhukov O; Qu K; Thompson AR
Haemophilia; 2007 May; 13(3):317-22. PubMed ID: 17498082
[TBL] [Abstract][Full Text] [Related]
19. Circulating anticoagulants.
Zieve PD; Levin J
Major Probl Intern Med; 1976; 10():65-70. PubMed ID: 785117
[No Abstract] [Full Text] [Related]
20. Effect of activated recombinant human factor 7 (Niastase) on laboratory testing of inhibitors of factors VIII and IX.
Keeney M; Allan DS; Lohmann RC; Yee IH
Lab Hematol; 2005; 11(2):118-23. PubMed ID: 16024335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
